Cargando…

Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation

PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR...

Descripción completa

Detalles Bibliográficos
Autores principales: Markiewicz, Miroslaw, Dzierzak-Mietla, Monika, Frankiewicz, Andrzej, Zielinska, Patrycja, Koclega, Anna, Kruszelnicka, Malgorzata, Kyrcz-Krzemien, Slawomira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411282/
https://www.ncbi.nlm.nih.gov/pubmed/22736463
http://dx.doi.org/10.1007/s00520-012-1489-5
_version_ 1782239803072315392
author Markiewicz, Miroslaw
Dzierzak-Mietla, Monika
Frankiewicz, Andrzej
Zielinska, Patrycja
Koclega, Anna
Kruszelnicka, Malgorzata
Kyrcz-Krzemien, Slawomira
author_facet Markiewicz, Miroslaw
Dzierzak-Mietla, Monika
Frankiewicz, Andrzej
Zielinska, Patrycja
Koclega, Anna
Kruszelnicka, Malgorzata
Kyrcz-Krzemien, Slawomira
author_sort Markiewicz, Miroslaw
collection PubMed
description PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR), we compared it with customary care—topical mouth solutions—on measures of severity and consequent interventions and complications. METHODS: In this randomized controlled trial, 40 patients undergoing allogeneic HSCT were randomized: 20 to SCPR four times daily and 20 to solutions made with salvia leaf extract, iodine-povidine, and fluconazole. Treatment extended from initiation of conditioning treatment until the granulocyte count was ≥0.2 g/L. Mucositis severity was measured daily by a hematologist according to a World Health Organization (WHO) scale and self-assessed by patients. Need for interventions [analgesics, total parenteral nutrition (TPN), and granulocyte colony-stimulating factor] and complications (acute graft-versus-host disease and infections) were also assessed. RESULTS: In comparison with the control group, the SCPR group had significantly lower mean measures of WHO oral toxicity (0.9 vs. 1.8; P = 0.02), disease course (3.2 vs. 7.1 days; P = 0.02), and peak mouth pain (0.85 vs. 1.75; P = 0.005). Analgesic need was significantly shorter (1.1 vs. 3.4 days; P = 0.047) and the need for TPN significantly lower (0 vs. 6 patients; P = 0.02; 0 vs. 1.9 mean days; P = 0.009). Measures of complications were lower in the SCPR group, but not significantly so. Trial limitations include the impracticality of achieving double blinding with agents so different in appearance and in preadministration preparation. CONCLUSIONS: Compared with the control group, the SCPR group had significantly lower mean measures of oral toxicity, peak mouth pain, and disease course duration. These results warrant confirmation in controlled, multicenter, randomized trials.
format Online
Article
Text
id pubmed-3411282
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-34112822012-08-23 Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation Markiewicz, Miroslaw Dzierzak-Mietla, Monika Frankiewicz, Andrzej Zielinska, Patrycja Koclega, Anna Kruszelnicka, Malgorzata Kyrcz-Krzemien, Slawomira Support Care Cancer Short Communication PURPOSE: Of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), 75 % or more experience oral mucositis, a painful acute complication that can delay discharge, interrupt treatment, and threaten life. To evaluate the efficacy of a supersaturated calcium phosphate rinse (SCPR), we compared it with customary care—topical mouth solutions—on measures of severity and consequent interventions and complications. METHODS: In this randomized controlled trial, 40 patients undergoing allogeneic HSCT were randomized: 20 to SCPR four times daily and 20 to solutions made with salvia leaf extract, iodine-povidine, and fluconazole. Treatment extended from initiation of conditioning treatment until the granulocyte count was ≥0.2 g/L. Mucositis severity was measured daily by a hematologist according to a World Health Organization (WHO) scale and self-assessed by patients. Need for interventions [analgesics, total parenteral nutrition (TPN), and granulocyte colony-stimulating factor] and complications (acute graft-versus-host disease and infections) were also assessed. RESULTS: In comparison with the control group, the SCPR group had significantly lower mean measures of WHO oral toxicity (0.9 vs. 1.8; P = 0.02), disease course (3.2 vs. 7.1 days; P = 0.02), and peak mouth pain (0.85 vs. 1.75; P = 0.005). Analgesic need was significantly shorter (1.1 vs. 3.4 days; P = 0.047) and the need for TPN significantly lower (0 vs. 6 patients; P = 0.02; 0 vs. 1.9 mean days; P = 0.009). Measures of complications were lower in the SCPR group, but not significantly so. Trial limitations include the impracticality of achieving double blinding with agents so different in appearance and in preadministration preparation. CONCLUSIONS: Compared with the control group, the SCPR group had significantly lower mean measures of oral toxicity, peak mouth pain, and disease course duration. These results warrant confirmation in controlled, multicenter, randomized trials. Springer-Verlag 2012-06-27 2012 /pmc/articles/PMC3411282/ /pubmed/22736463 http://dx.doi.org/10.1007/s00520-012-1489-5 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Short Communication
Markiewicz, Miroslaw
Dzierzak-Mietla, Monika
Frankiewicz, Andrzej
Zielinska, Patrycja
Koclega, Anna
Kruszelnicka, Malgorzata
Kyrcz-Krzemien, Slawomira
Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title_full Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title_fullStr Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title_full_unstemmed Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title_short Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
title_sort treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411282/
https://www.ncbi.nlm.nih.gov/pubmed/22736463
http://dx.doi.org/10.1007/s00520-012-1489-5
work_keys_str_mv AT markiewiczmiroslaw treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT dzierzakmietlamonika treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT frankiewiczandrzej treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT zielinskapatrycja treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT koclegaanna treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT kruszelnickamalgorzata treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation
AT kyrczkrzemienslawomira treatingoralmucositiswithasupersaturatedcalciumphosphaterinsecomparisonwithcontrolinpatientsundergoingallogeneichematopoieticstemcelltransplantation